CAMBRIDGE, Mass.


,


Sept. 1, 2022


/PRNewswire/ —

Akebia Therapeutics, Inc.

(Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that

John Butler

, Chief Executive Officer, will present virtually at the H.C. Wainwright 24

^th

Annual Global Investment Conference. The hybrid conference will take place September 12–14, 2022.

The presentation will be available on-demand beginning

September 12, 2022

through the Investors section of Akebia’s website at

https://ir.akebia.com

for approximately 90 days.

About Akebia Therapeutics


Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in

Cambridge, Massachusetts

. For more information, please visit our website at

www.akebia.com

, which does not form a part of this release.

Akebia Therapeutics Contact



Mercedes Carrasco



[email protected]

View original content to download multimedia:

https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-virtually-at-the-hc-wainwright-24th-annual-global-investment-conference-301615782.html

SOURCE Akebia Therapeutics